SCHEMBL13625182

SCHEMBL13625182

Bc1c(I)c2c(N)ncnn2c1C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.33
FGFR3 P22607 2/20 0.33
PLK4 O00444 1/20 0.33
AURKA O14965 1/20 0.33
DAPK3 O43293 1/20 0.33
ROCK2 O75116 1/20 0.33
PAK4 O96013 1/20 0.33
CHEK2 O96017 1/20 0.33
ABL1 P00519 1/20 0.33
NTRK1 P04629 1/20 0.33
INSR P06213 1/20 0.33
LCK P06239 1/20 0.33
FYN P06241 1/20 0.33
CSF1R P07333 1/20 0.33
LYN P07948 1/20 0.33
IGF1R P08069 1/20 0.33
MET P08581 1/20 0.33
KIT P10721 1/20 0.33
PIM1 P11309 1/20 0.33
SRC P12931 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10118032 0.83 RET (0.37) FGFR1FGFR3PLK4AURKADAPK3
SCHEMBL13625181 0.83 FGFR1 (0.34) FGFR1FGFR3PLK4AURKADAPK3
SCHEMBL13625183 0.75 FGFR1 (0.42) FGFR1FGFR3PLK4AURKADAPK3
SCHEMBL19697994 0.73 ACVRL1 (0.32) ACVRL1PDE2A
SCHEMBL279415 0.73 FGFR1 (0.39) FGFR1FGFR3PLK4AURKADAPK3
SCHEMBL13625180 0.72 FGFR1 (0.55) FGFR1FGFR3PLK4AURKADAPK3
SCHEMBL10118030 0.72 FGFR1 (0.38) FGFR1FGFR3PLK4AURKADAPK3
SCHEMBL19280465 0.69 PIK3CD (0.35) FGFR1FGFR3KDRACVRL1RET
SCHEMBL279494 0.69 FGFR1 (0.37) FGFR1FGFR3PLK4AURKADAPK3
SCHEMBL279456 0.69 FGFR1 (0.34) FGFR1FGFR3PLK4AURKADAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140200198-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2014-07-17 US disclosed
WO-2009136966-A1 INHIBITORS OF PROTEIN KINASES ABBOTT LABORATORIES (US) 2009-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140200198-A1 BORON-CONTAINING SMALL MOLECULES BTD, BCL6B, BBOX1 FGFR1 3266/4885FGFR3 2138/4885PLK4 4654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.